Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids
- PMID: 33005290
- PMCID: PMC7510001
- DOI: 10.4251/wjgo.v12.i9.942
Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids
Abstract
5-flurouracil (5-FU)-based chemotherapy is the main pharmacological therapy for advanced colorectal cancer (CRC). Despite significant progress in the treatment of CRC during the last decades, 5-FU drug resistance remains the most important cause of failure in CRC therapy. Resistance to 5-FU is a complex and multistep process. Different mechanisms including microsatellite instability, increased expression level of key enzyme thymidylate synthase and its polymorphism, increased level of 5-FU-activating enzymes and mutation of TP53 are proposed as the main determinants of resistance to 5-FU in CRC cells. Recently, micro-ribonucleic acids (miRNA) and their alterations were found to have a crucial role in 5-FU resistance. In this regard, the miRNA-mediated mechanisms of 5-FU drug resistance reside among the new fields of pharmacogenetics of CRC drug response that has not been completely discovered. Identification of the biological markers that are related to response to 5-FU-based chemotherapy is an emerging field of precision medicine. This approach will have an important role in defining those patients who are most likely to benefit from 5-FU-based chemotherapy in the future. Thereby, the identification of 5-FU drug resistance mechanisms is an essential step to predict and eventually overcome resistance. In the present comprehensive review, we will summarize the latest knowledge regarding the molecular determinants of response to 5-FU-based chemotherapy in CRC by emphasizing the role of miRNAs.
Keywords: 5-flurouracil; Chemotherapy resistance, Thymidylate synthase; Colorectal cancer; Micro-ribonucleic acid; Microsatellite instability; TP53.
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare no potential financial interests.
Figures



Similar articles
-
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future.Pharmacol Ther. 2020 Feb;206:107447. doi: 10.1016/j.pharmthera.2019.107447. Epub 2019 Nov 19. Pharmacol Ther. 2020. PMID: 31756363 Review.
-
MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.Carcinogenesis. 2015 Dec;36(12):1484-93. doi: 10.1093/carcin/bgv145. Epub 2015 Oct 6. Carcinogenesis. 2015. PMID: 26442524
-
Elevated microRNA-23a Expression Enhances the Chemoresistance of Colorectal Cancer Cells with Microsatellite Instability to 5-Fluorouracil by Directly Targeting ABCF1.Curr Protein Pept Sci. 2015;16(4):301-9. doi: 10.2174/138920371604150429153309. Curr Protein Pept Sci. 2015. PMID: 25929864
-
Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.Acta Oncol. 2008;47(6):1046-53. doi: 10.1080/02841860701678753. Acta Oncol. 2008. PMID: 17943475
-
[Recent advance in chemotherapy for advanced colorectal cancer].Gan To Kagaku Ryoho. 1996 Apr;23(5):535-48. Gan To Kagaku Ryoho. 1996. PMID: 8678510 Review. Japanese.
Cited by
-
miRNA Clusters with Up-Regulated Expression in Colorectal Cancer.Cancers (Basel). 2021 Jun 14;13(12):2979. doi: 10.3390/cancers13122979. Cancers (Basel). 2021. PMID: 34198662 Free PMC article. Review.
-
Ulva pertusa Modulated Colonic Oxidative Stress Markers and Clinical Parameters: A Potential Adjuvant Therapy to Manage Side Effects During 5-FU Regimen.Int J Mol Sci. 2024 Dec 3;25(23):12988. doi: 10.3390/ijms252312988. Int J Mol Sci. 2024. PMID: 39684698 Free PMC article.
-
Natural polymer derivative-based pH-responsive nanoformulations with entrapped diketo-tautomers of 5-fluorouracil for enhanced cancer therapy.ADMET DMPK. 2025 Jan 3;13(1):2554. doi: 10.5599/admet.2554. eCollection 2025. ADMET DMPK. 2025. PMID: 40161888 Free PMC article.
-
Folate-Associated Gene Expression in Primary Tumors Is Associated With Tumor Response and Progression-Free Survival of Patients With Metastatic Colorectal Cancer Undergoing 5-FU/Leucovorin-Based Combination Chemotherapy.Cancer Med. 2025 May;14(9):e70895. doi: 10.1002/cam4.70895. Cancer Med. 2025. PMID: 40357991 Free PMC article.
-
From Chemical Composition to Antiproliferative Effects Through In Vitro Studies: Honey, an Ancient and Modern Hot Topic Remedy.Nutrients. 2025 May 6;17(9):1595. doi: 10.3390/nu17091595. Nutrients. 2025. PMID: 40362904 Free PMC article. Review.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
-
- Malet-Martino M, Jolimaitre P, Martino R. The prodrugs of 5-fluorouracil. Curr Med Chem Anticancer Agents. 2002;2:267–310. - PubMed
-
- Eftekhar E, Naghibalhossaini F. Carcinoembryonic antigen expression level as a predictive factor for response to 5-fluorouracil in colorectal cancer. Mol Biol Rep. 2014;41:459–466. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous